SDH Subunit Mutation Status in Saliva: Genetic Testing in Patients with Pheochromocytoma

Abstract

Germline mutations occur in up to 30–40% of pheochromocytoma/paraganglioma, with mutations in the succinate dehydrogenase (SDH) subunits B (SDHB) and D (SDHD) being the most common. Blood samples are favored for obtaining high quality DNA, however, leukocytes can also be obtained by collecting saliva. The aim of this study was to determine whether SDHB and SDHD gene mutations in patients with pheochromocytoma/paraganglioma could be determined using a salivary sample. Paired blood and salivary samples were collected from 30 patients: 9 SDHB mutation positive, 13 with a SDHD mutation, and 8 without any SDHx mutations. The Oragene DISCOVER kit was used to collect and extract DNA from saliva. Blood DNA was extracted from EDTA blood samples. The DNA purification and concentration were measured by spectrophotometry. The 8 exons of SDHB and the 4 exons of SDHD were amplified and sequenced by PCR-based bidirectional Sanger sequencing. Total DNA yields from blood DNA were similar to those obtained from saliva DNA [mean (±SD) saliva vs. blood DNA concentration 514.6 (±580.8) ng/µl vs. 360.9 (±262.7) ng/µl; p=0.2)]. The purity of the saliva DNA samples was lower than that of blood [mean OD₂₆₀/OD₂₈₀ ratio 1.78 (±0.13) vs. 1.87 (±0.04); p=0.001, respectively], indicating more protein contamination in the saliva-extracted DNA. This study shows that salivary DNA collected from patients with pheochromocytoma/paraganglioma is a good alternative for extraction of genomic DNA for its high DNA concentration and acceptable purity and can be used as an alternative to blood derived DNA in screening for SDHB and SDHD mutations.

Key words

SDHx mutations - pheochromocytoma - paraganglioma - DNA - saliva

• References

• 1 Favier J, Amar L, Gimenez-Roqueplo AP. Paraganglioma and phaeochromocytoma: From genetics to personalized medicine. Nat Rev Endocrinol 2014; 11: 101-111
• 2 Martucci VL, Pacak K. Pheochromocytoma and paraganglioma: Diagnosis, genetics, management, and treatment. Curr Probl Cancer 2014; 38: 7-41
• 3 Lee CH, Cheung CY, Chow WS, Woo YC, Yeung CY, Lang BH, Fong CH, Kwok KH, Chen SP, Mak CM, Tan KC, Lam KS. Genetics of apparently sporadic pheochromocytoma and paraganglioma in a chinese population. Horm Metab Res 2015; 47: 833-838
• 4 Pai R, Ebenazer A, Paul MJ, Thomas N, Nair A, Seshadri MS, Oommen R, Shanthly N, Devasia A, Rebekah G, Jeyaseelan L, Rajaratnam S. Mutations seen among patients with pheochromocytoma and paraganglioma at a referral center from india. Horm Metab Res 2015; 47: 133-137
• 5 Jochmanová I, Zhuang Z, Pacak K. Pheochromocytoma: Gasping for air. Horm Cancer 2015; 6: 191-205
• 6 Matro J, Giubellino A, Pacak K. Current and future therapeutic approaches for metastatic pheochromocytoma and paraganglioma: Focus on SDHB tumors. Horm Metab Res 2013; 45: 147-153
• 7 Neumann HPH, Eng C. The approach to the patient with paraganglioma. J Clin Endocrinol Metab 2009; 94: 2677-2683
• 8 Xekouki P, Pacak K, Almeida M, Wassif CA, Rustin P, Nesterova M, de la Luz Sierra M, Matro J, Ball E, Azevedo M, Horvath A, Lyssikatos C, Quezado M, Patronas N, Ferrando B, Pasini B, Lytras A, Tolis G, Stratakis CA. Succinate dehydrogenase (SDH) D subunit (SDHD) inactivation in a growth-hormone-producing pituitary tumor: A new association for SDH?. J Clin Endocrinol Metab 2012; 97: E357-E366
• 9 Bandhakavi S, Stone MD, Onsongo G, Van Riper SK, Griffin TJ. A dynamic range compression and 3-dimensional peptide fractionation analysis 20 platform expands proteome coverage and the diagnostic potential of whole saliva. J Proteome Res 2009; 8: 5590-5600